Marksans Pharma arm New York facility gets 1 USFDA observation Ruchika Sharma28 April 2025 11:30 AM ISTMumbai: Marksans Pharma has announced that the US Food and Drug Administration (USFDA) has concluded an inspection with one...
Marksans Pharma Goa facility gets Australian nod to manufacture pharma formulations for Australian markets Ruchika Sharma20 March 2025 10:30 AM ISTMumbai: Marksans Pharma Limited has announced that its manufacturing facility located at Plot A-1, Phase 1-A, Verna Industrial Estate, Verna,...
Marksans Pharma arm gets marketing authorization for muscle relaxant tablets in UK Ruchika Sharma19 March 2025 2:30 PM ISTMumbai: Marksans Pharma Limited's wholly owned subsidiary in the UK, Relonchem Limited receives marketing authorization for the product Baclofen...
Marksans Pharma UK arm gets marketing nod for Ibuprofen, Paracetamol Film-coated Tablets Ruchika Sharma26 Feb 2025 12:43 PM ISTMumbai: Marksans Pharma Limited has announced that its wholly owned subsidiary in UK RelonchemLimited has received Marketing...
Marksans Pharma Secures USFDA Nod for Generic Version of Clartin Tablet Farhat Nasim22 Nov 2024 3:03 PM ISTMarksans' product, Loratadine Tablets USP 10 mg are indicated for the treatment of allergic rhinitis.
Marksans Pharma subsidiary Relonchem bags marketing authorization from UK MHRA for Fluoxetine Capsules Ruchika Sharma22 Aug 2024 3:25 PM ISTMumbai: Marksans Pharma Limited has announced that its wholly owned subsidiary Relonchem Limited has received Marketing Authorization from...
USFDA issues EIR for Marksans Pharma Goa facility Ruchika Sharma20 Aug 2024 4:45 PM ISTMumbai: Marksans Pharma has announced that the US Food and Drug Administration (USFDA) has issued an Establishment Inspection Report (EIR) for...
Marksans Pharma arm gets UK MHRA marketing authorization for oral emergency contraceptive pill Ruchika Sharma2 Aug 2024 1:30 PM ISTMumbai: Marksans Pharma Limited has announced that its wholly owned subsidiary Relonchem Limited has received Marketing Authorization for the...
Marksans Pharma arm bags UKMHRA marketing authorization for Rasagiline Relonchem, Olmesartan tablets Ruchika Sharma2 July 2024 5:13 PM ISTMumbai: Marksans Pharma has announced that its wholly-owned subsidiary Relonchem Limited has received Marketing Authorization from UKMHRA...
Marksans Pharma arm Relonchem bags UK MHRA marketing nod for oral solution to treat epilepsy Ruchika Sharma28 May 2024 3:49 PM ISTMumbai: Marksans Pharma Limited has announced that its wholly owned subsidiary Relonchem Limited has received Marketing Authorization for the...
Marksans Pharma gets 5 inspectional observations from USFDA for Goa facility Ruchika Sharma18 April 2024 12:14 PM ISTMumbai: Marksans Pharma has received 5 inspectional observations in Form 483 from the US Food and Drug Administration (USFDA) at...
Marksans Pharma arm gets marketing authorisation for Cyanocobalamin 50mg film coated tablets from UK MHRA Ruchika Sharma6 Nov 2023 4:30 PM ISTMumbai: Marksans Pharma Limited has announced that its wholly owned subsidiary Relonchem Limited has received Marketing Authorisation for the...
